MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 325.84% | 15.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 164.71% | 2.72% | |||
| Operating Income | -164.71% | -2.72% | |||
| Income Before Tax | -170.41% | 1.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -170.41% | 1.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -170.41% | 1.43% | |||
| EBIT | -164.71% | -2.72% | |||
| EBITDA | -165.41% | -2.73% | |||
| EPS Basic | 93.35% | 4.93% | |||
| Normalized Basic EPS | 93.23% | 5.55% | |||
| EPS Diluted | 93.35% | 4.93% | |||
| Normalized Diluted EPS | 93.23% | 5.55% | |||
| Average Basic Shares Outstanding | 3,963.84% | 3.67% | |||
| Average Diluted Shares Outstanding | 3,963.84% | 3.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||